During the past decade, New Puerto Rico CONCRA conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "New Puerto Rico CONCRA" are "HIV Infections" (2 trials). Many other conditions were trialed in "New Puerto Rico CONCRA" in a lesser frequency.

Most popular intervention types in "New Puerto Rico CONCRA" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Amprenavir/ritonavir" (2 trials), "Saquinavir/ritonavir" (2 trials) and "Efavirenz" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Puerto Rico CONCRA" are 2 trials for "All" genders.

Currently, there are NaN active trials in "New Puerto Rico CONCRA". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in New Puerto Rico CONCRA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in New Puerto Rico CONCRA, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".